首页> 外文会议>World Asthma and COPD Forum >The tyranny of rare diseases
【24h】

The tyranny of rare diseases

机译:稀有疾病的暴政

获取原文

摘要

There are a number of common respiratory diseases which on presentation resemble different and much less common disorders, many of which are lethal if untreated. Many of these conditions may present only once every year to every several years, and so the diagnosis is easily missed, or can be delayed until complications have arisen and the treatment and prognosis is much less certain. In our Department we have had a number of such conditions referred to us over the past few years. One such disease which occurs in asthma is Churg Strauss Syndrome (CSS), a systemic necrotizing vasculitis. A ten year study in the Norwich Health Authority of the United Kingdom found that the prevalence of Churg Strauss Syndrome (CSS) was 2.7 per million, or 3.4 per million, depending on the definition of the disease (1) When compared with the prevalence of asthma in adults (8.3%, or 83,000 per million) (2), it is easy to see how it can be missed. The solution is also not to screen for these diseases in every patient as a lot of unnecessary tests will be done, increasing cost and potentially morbidity of testing. Hence, one must be aware of factors that increase the pre-test probability of the diagnosis, factors colloquially known as "red flags".
机译:有许多常见的呼吸系统疾病,其上呈现类似的不同和更常见疾病,如果不进行治疗其中有许多是致命的。许多这些条件可能会出现每年只有一次,每隔几年,所以诊断容易漏诊,或可延迟至并发症出现以及治疗和预后是肯定要少得多。在我们的部门,我们有一些在过去几年中我们介绍给这样的条件。发生在哮喘一种这样的疾病是丘 - 斯综合征(CSS),系统性坏死性血管炎。在英国的诺维奇卫生局一个10年的研究发现,丘 - 斯综合征(CSS)的患病率为每百万2.7,或每百万3.4,视病情(1)的定义,当患病率比较哮喘成人(8.3%,或每百万83000)(2),很容易看到它如何能错过。该解决方案还没有来筛选这些疾病在每一个病人为很多不必要的检查也多,增加了成本和检测潜在的发病率。因此,人们必须了解的因素增加的诊断,俗称为“红旗”的因素的预测试概率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号